Skip to search formSkip to main contentSkip to account menu

omadacycline

Known as: (4S,4aS,5aR,12aS)-4,7-bis(dimethylamino)-9-{[(2,2-dimethylpropyl)amino]methyl}- 3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2- carboxamide 
National Institutes of Health

Related topics

Related topics

1 relation
Omadacycline:Susc:Pt:Isolate:OrdQn:MIC

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Surveillance of Omadacycline Activity Tested against Clinical Isolates from the United States and Europe: Report from the SENTRY Antimicrobial Surveillance Program, 2016 to 2018
Omadacycline is a broad-spectrum aminomethylcycline approved in October 2018 by the U.S. Food and Drug Administration for… 
Highly Cited
2019
Highly Cited
2019
In Vitro Activities of Omadacycline against Rapidly Growing Mycobacteria
The in vitro activity of omadacycline, a new tetracycline derivative, was evaluated against isolates of Mycobacterium abscessus… 
Highly Cited
2019
Highly Cited
2019
In Vitro Activity of New Tetracycline Analogs Omadacycline and Eravacycline against Drug-Resistant Clinical Isolates of Mycobacterium abscessus
Tigecycline is used in multidrug regimens for salvage therapy of Mycobacterium abscessus infections but is often poorly tolerated… 
Review
2019
Review
2019
Microbiology and Preclinical Review of Omadacycline
Abstract Omadacycline is a novel aminomethylcycline antimicrobial and semisynthetic derivative of tetracycline. In vitro… 
2019
2019
Omadacycline as a promising new agent for the treatment of infections with Mycobacterium abscessus
Abstract Background Despite intensive treatment regimens, the outcome of Mycobacterium abscessus infections is extremely poor and… 
2019
2019
Omadacycline for Acute Bacterial Skin and Skin Structure Infections
Abstract Background Within the last decade, methicillin-resistant Staphylococcus aureus (MRSA) has emerged as a frequent cause of… 
Review
2017
Review
2017
Antibiotics in late clinical development
Review
2017
Review
2017
New and improved? A review of novel antibiotics for Gram-positive bacteria.
2017
2017
Pharmacokinetics and Safety of Omadacycline in Subjects with Impaired Renal Function
ABSTRACT Many antibiotics require dose adjustments in patients with renal impairment and/or in those undergoing hemodialysis… 
Highly Cited
2013
Highly Cited
2013
In Vitro and In Vivo Antibacterial Activities of Omadacycline, a Novel Aminomethylcycline
ABSTRACT Omadacycline is the first intravenous and oral 9-aminomethylcycline in clinical development for use against multiple… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)